Explore All Access
Check if your research matches the topics covered in Cancer Chemotherapy and Pharmacology?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Cancer Chemotherapy and Pharmacology : Impact Factor & More
eISSN: 1432-0843pISSN: 0344-5704
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Aims and Scope
Cancer Chemotherapy and Pharmacology is a peer-reviewed medical journal covering oncological pharmacotherapy. It was established in 1978 and is published by Springer Science+Business Media. The editors-in-chief are E.Chatelut (Paul Sabatier University) and E.A. Sausville (University of Maryland). It has been included in Index medicus (MEDLINE) since its first issue. According to the ISI 2016 Journal Citation Reports, the journal has an impact factor of 2.737, and its ranking was 98/254 (Pharmacology & Pharmacy) and 122/217 (Oncology). Less
Cancer Chemotherapy and Pharmacology Key Metrics
CiteScore 
5.9
Impact Factor
< 5
SJR
Q2Oncology
SNIP
0.96
Time to Publish
View Chart Mo
Time to Publish
Sign up now and unlock a detailed chart of Time to publish for this journal
% of papers by time taken from submission to publication
0 to 3 months25%
4 to 6 months60%
7 to 9 months12%
Above 9 months2%
Did you find this useful?
Topics Covered on Cancer Chemotherapy and Pharmacology
Chemotherapy
Cancer
Lipid metabolism
Lung cancer
DNA repair
Methotrexate
Oral administration
Hepatocellular carcinoma
Bioavailability
Breast cancer
Toxicity
Irinotecan
Initial dose
Epidermal growth factor receptor
Crizotinib
Mitochondrial targeting
Overall survival
Renal function
Cisplatin
Diarrhea
Cancer Chemotherapy and Pharmacology Journal Specifications
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1978 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Cancer Chemotherapy and Pharmacology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cancer Chemotherapy and Pharmacology
Successful desensitization in a patient with metastatic colorectal cancer presenting with regorafenib-mediated fix drug eruption.
- 19 Oct 2024
- Cancer chemotherapy and pharmacology
An intracerebral microdialysis study to determine the neuropharmacokinetics of eribulin in patients with metastatic or primary brain tumors.
- 18 Oct 2024
- Cancer chemotherapy and pharmacology
Retraction Note: NO donor inhibits proliferation and induces apoptosis by targeting PI3K/AKT/mTOR and MEK/ERK pathways in hepatocellular carcinoma cells.
- 16 Oct 2024
- Cancer chemotherapy and pharmacology
A comparison of the renal function biomarkers serum creatinine, pro-enkephalin and cystatin C to predict clearance of pemetrexed.
- 4 Oct 2024
- Cancer chemotherapy and pharmacology
Ferroptosis - a potential feature underlying neratinib-induced colonic epithelial injury.
- 1 Oct 2024
- Cancer chemotherapy and pharmacology
Avermectin B1 mediates antitumor activity and induces autophagy in osteosarcoma through the AMPK/ULK1 signaling pathway.
- 1 Oct 2024
- Cancer chemotherapy and pharmacology
Successful desensitization in a patient with metastatic colorectal cancer presenting with regorafenib-mediated fix drug eruption.
- 19 Oct 2024
- Cancer chemotherapy and pharmacology
An intracerebral microdialysis study to determine the neuropharmacokinetics of eribulin in patients with metastatic or primary brain tumors.
- 18 Oct 2024
- Cancer chemotherapy and pharmacology
Retraction Note: NO donor inhibits proliferation and induces apoptosis by targeting PI3K/AKT/mTOR and MEK/ERK pathways in hepatocellular carcinoma cells.
- 16 Oct 2024
- Cancer chemotherapy and pharmacology
A comparison of the renal function biomarkers serum creatinine, pro-enkephalin and cystatin C to predict clearance of pemetrexed.
- 4 Oct 2024
- Cancer chemotherapy and pharmacology
Ferroptosis - a potential feature underlying neratinib-induced colonic epithelial injury.
- 1 Oct 2024
- Cancer chemotherapy and pharmacology
Avermectin B1 mediates antitumor activity and induces autophagy in osteosarcoma through the AMPK/ULK1 signaling pathway.
- 1 Oct 2024
- Cancer chemotherapy and pharmacology
Compare Similar Journals with Cancer Chemotherapy and Pharmacology
Select Journals to Compare with Cancer Chemotherapy and Pharmacology
Total journals - 9
You can select up to 3 Journals at a time
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Annals of Oncology
Publisher: ELSEVIER
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Clinical Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Cancers
Publisher: MDPI
BMC Cancer
Publisher: BMC
European Journal of Cancer
Publisher: ELSEVIER SCI LTD
Oncotarget
Publisher: Impact Journals
0 Journals Selected to compare with
Cancer Chemotherapy and Pharmacology
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Cancer Chemotherapy and Pharmacology
How long has Cancer Chemotherapy and Pharmacology been actively publishing? 
Cancer Chemotherapy and Pharmacology has been in operation since 1978 till date.
What is the publishing frequency of Cancer Chemotherapy and Pharmacology?
Cancer Chemotherapy and Pharmacology published with a Monthly frequency.
How many articles did Cancer Chemotherapy and Pharmacology publish last year?
In 2023, Cancer Chemotherapy and Pharmacology publsihed 126 articles.
What is the eISSN & pISSN for Cancer Chemotherapy and Pharmacology?
For Cancer Chemotherapy and Pharmacology, eISSN is 1432-0843 and pISSN is 0344-5704.
What is Citescore for Cancer Chemotherapy and Pharmacology?
Citescore for Cancer Chemotherapy and Pharmacology is 5.9.
What is SNIP score for Cancer Chemotherapy and Pharmacology?
SNIP score for Cancer Chemotherapy and Pharmacology is 0.96.
What is the SJR for Cancer Chemotherapy and Pharmacology?
SJR for Cancer Chemotherapy and Pharmacology is Q2.
Who is the publisher of Cancer Chemotherapy and Pharmacology?
SPRINGER is the publisher of Cancer Chemotherapy and Pharmacology.
